Manulife (Manufacturers Life Insurance)
HBIO icon

Manulife (Manufacturers Life Insurance)’s Harvard Bioscience HBIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,656
Closed -$70.2K – 3002
2024
Q1 		$70.2K Buy
1,656
+8
+0.5% +$360 ﹤0.01% 2857
2023
Q4 		$88.2K Hold
1,648
– – ﹤0.01% 2850
2023
Q3 		$70.9K Hold
1,648
– – ﹤0.01% 2897
2023
Q2 		$90.5K Buy
+1,648
New +$90.4K ﹤0.01% 2876
2022
Q2 		– Sell
-1,798
Closed -$112K – 3061
2022
Q1 		$112K Sell
1,798
-486
-21% -$28.7K ﹤0.01% 2946
2021
Q4 		$161 Sell
2,284
-20
-0.9% -$1.42K ﹤0.01% 2967
2021
Q3 		$161K Sell
2,304
-185
-7% -$14.7K ﹤0.01% 3048
2021
Q2 		$207K Sell
2,489
-48
-2% -$3.4K ﹤0.01% 3079
2021
Q1 		$139K Sell
2,537
-232
-8% -$11.3K ﹤0.01% 2997
2020
Q4 		$119K Buy
2,769
+104
+4% +$3.88K ﹤0.01% 2930
2020
Q3 		$80K Hold
2,665
– – ﹤0.01% 2839
2020
Q2 		$83K Buy
+2,665
New +$71.8K ﹤0.01% 2802
2019
Q2 		– Sell
-2,715
Closed -$117K – 2926
2019
Q1 		$117K Buy
2,715
+33
+1% +$1.2K ﹤0.01% 2558
2018
Q4 		$85K Buy
2,682
+44
+2% +$1.73K ﹤0.01% 2455
2018
Q3 		$138K Sell
2,638
-348
-12% -$19.5K ﹤0.01% 2855
2018
Q2 		$160K Buy
2,986
+2,937
+5,994% +$150K ﹤0.01% 3274
2018
Q1 		$2K Sell
49
-161
-77% -$7.22K ﹤0.01% 4226
2017
Q4 		$7K Sell
210
-47
-18% -$1.59K ﹤0.01% 4066
2017
Q3 		$10K Buy
257
+63
+32% +$1.86K ﹤0.01% 3830
2017
Q2 		$5K Buy
194
+18
+10% +$445 ﹤0.01% 3940
2017
Q1 		$5K Hold
176
– – ﹤0.01% 3786
2016
Q4 		$5K Hold
176
– – ﹤0.01% 3929
2016
Q3 		$5K Hold
176
– – ﹤0.01% 3870
2016
Q2 		$5K Sell
176
-2,415
-93% -$76.8K ﹤0.01% 3791
2016
Q1 		$78K Buy
2,591
+441
+21% +$12.5K ﹤0.01% 3153
2015
Q4 		$74 Hold
2,150
– – ﹤0.01% 3182
2015
Q3 		$81 Sell
2,150
-683
-24% -$31.8K ﹤0.01% 3210
2015
Q2 		$161 Buy
+2,833
New +$161K ﹤0.01% 3040
2013
Q4 		– Sell
-1,756
Closed -$70 – 3841
2013
Q3 		$70 Sell
1,756
-33
-2% -$1.3K ﹤0.01% 3097
2013
Q2 		$64K Buy
+1,789
New +$68.5K ﹤0.01% 3061

Other funds holding HBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HBIO Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Harvard Bioscience (HBIO) in Q2 2024, closing a stake of 1,656 shares — an estimated $70.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in HBIO in Q2 2013 and held it in 30 quarters. The position peaked at $207K in Q2 2021. 100 funds tracked by Wall St. Rank hold HBIO as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Harvard Bioscience position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,656 Harvard Bioscience shares in Q2 2024, an estimated $70.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Harvard Bioscience in Q2 2013 and held it in 30 quarters.
  • Manulife (Manufacturers Life Insurance)'s Harvard Bioscience position peaked at $207K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.